Cart
sales@molnova.com
OsMundacetone
CAS No. 37079-84-8
OsMundacetone( —— )
Catalog No. M20437 CAS No. 37079-84-8
OsMundacetone is a natual product isolated from Rhizoma osmundae.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 88 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 158 | In Stock |
|
| 25MG | 263 | In Stock |
|
| 50MG | 369 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOsMundacetone
-
NoteResearch use only, not for human use.
-
Brief DescriptionOsMundacetone is a natual product isolated from Rhizoma osmundae.
-
DescriptionOsMundacetone is a natual product isolated from Rhizoma osmundae.
-
In VitroOsmundacetone significantly suppresses the phosphorylation of MAPKs, including JNK, ERK, and p38 kinases.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number37079-84-8
-
Formula Weight178.18
-
Molecular FormulaC10H10O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (561.23 mM)
-
SMILESCC(=O)\C=C\c1ccc(O)c(O)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang D Li B W Yang L et al. Isolation and determination of osmundacetone in Osmundae Rhizoma[J]. Journal of Chinese Pharmaceutical Sciences 2010 45(21):1612-1614.
molnova catalog
related products
-
CEF10
CEF10
-
Secretin, porcine TF...
Secretin, porcine TFA (Porcine secretin TFA) is a 27-amino acid peptide, acting on pancreatic acinar cells and ductal epithelial cells stimulating the production of bicarbonate rich fluid.Secretin porcine stimulates pancreatic and gastric secretions to aid in the diagnosis of pancreatic exocrine dysfunction and the diagnosis of gastrinoma.
-
HA15
HA15 targets specifically BiP/GRP78/HSPA5. HA15 exhibits anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.
